Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1995 1
1996 1
1998 4
1999 1
2001 2
2002 1
2004 3
2005 2
2006 2
2007 6
2008 6
2009 2
2010 7
2011 5
2012 9
2013 8
2014 16
2015 12
2016 10
2017 10
2018 5
2019 4
2020 5
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 25180626

110 results
Results by year
Filters applied: . Clear all
Page 1
Binge alcohol consumption aggravates oxidative stress and promotes pathogenesis of NASH from obesity-induced simple steatosis.
Minato T, Tsutsumi M, Tsuchishima M, Hayashi N, Saito T, Matsue Y, Toshikuni N, Arisawa T, George J. Minato T, et al. Mol Med. 2014 Dec 10;20(1):490-502. doi: 10.2119/molmed.2014.00048. Mol Med. 2014. PMID: 25180626 Free PMC article.
CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis.
Abdelmegeed MA, Banerjee A, Jang S, Yoo SH, Yun JW, Gonzalez FJ, Keshavarzian A, Song BJ. Abdelmegeed MA, et al. Free Radic Biol Med. 2013 Dec;65:1238-1245. doi: 10.1016/j.freeradbiomed.2013.09.009. Epub 2013 Sep 21. Free Radic Biol Med. 2013. PMID: 24064383 Free PMC article.
Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver.
Gopal T, Kumar N, Perriotte-Olson C, Casey CA, Donohue TM Jr, Harris EN, Talmon G, Kabanov AV, Saraswathi V. Gopal T, et al. Am J Physiol Gastrointest Liver Physiol. 2020 Mar 1;318(3):G428-G438. doi: 10.1152/ajpgi.00217.2019. Epub 2020 Jan 13. Am J Physiol Gastrointest Liver Physiol. 2020. PMID: 31928222
Limited Excessive Voluntary Alcohol Drinking Leads to Liver Dysfunction in Mice.
Wegner SA, Pollard KA, Kharazia V, Darevsky D, Perez L, Roychowdhury S, Xu A, Ron D, Nagy LE, Hopf FW. Wegner SA, et al. Alcohol Clin Exp Res. 2017 Feb;41(2):345-358. doi: 10.1111/acer.13303. Epub 2017 Jan 19. Alcohol Clin Exp Res. 2017. PMID: 28103636 Free PMC article.
Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.
Linden MA, Sheldon RD, Meers GM, Ortinau LC, Morris EM, Booth FW, Kanaley JA, Vieira-Potter VJ, Sowers JR, Ibdah JA, Thyfault JP, Laughlin MH, Rector RS. Linden MA, et al. J Physiol. 2016 Sep 15;594(18):5271-84. doi: 10.1113/JP272235. Epub 2016 May 27. J Physiol. 2016. PMID: 27104887 Free PMC article.
Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects.
Kurita S, Takamura T, Ota T, Matsuzawa-Nagata N, Kita Y, Uno M, Nabemoto S, Ishikura K, Misu H, Ando H, Zen Y, Nakanuma Y, Kaneko S. Kurita S, et al. Eur J Pharmacol. 2008 Jul 7;588(2-3):316-24. doi: 10.1016/j.ejphar.2008.04.028. Epub 2008 Apr 16. Eur J Pharmacol. 2008. PMID: 18501344
Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
Ota T, Takamura T, Kurita S, Matsuzawa N, Kita Y, Uno M, Akahori H, Misu H, Sakurai M, Zen Y, Nakanuma Y, Kaneko S. Ota T, et al. Gastroenterology. 2007 Jan;132(1):282-93. doi: 10.1053/j.gastro.2006.10.014. Epub 2006 Oct 12. Gastroenterology. 2007. PMID: 17241878
Pioglitazone, quercetin and hydroxy citric acid effect on cytochrome P450 2E1 (CYP2E1) enzyme levels in experimentally induced non alcoholic steatohepatitis (NASH).
Surapaneni KM, Priya VV, Mallika J. Surapaneni KM, et al. Eur Rev Med Pharmacol Sci. 2014;18(18):2736-41. Eur Rev Med Pharmacol Sci. 2014. PMID: 25317811 Free article.
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM. Yamaguchi K, et al. Hepatology. 2007 Jun;45(6):1366-74. doi: 10.1002/hep.21655. Hepatology. 2007. PMID: 17476695
Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model.
Rector RS, Thyfault JP, Uptergrove GM, Morris EM, Naples SP, Borengasser SJ, Mikus CR, Laye MJ, Laughlin MH, Booth FW, Ibdah JA. Rector RS, et al. J Hepatol. 2010 May;52(5):727-36. doi: 10.1016/j.jhep.2009.11.030. Epub 2010 Mar 4. J Hepatol. 2010. PMID: 20347174 Free PMC article.
110 results
Jump to page
Feedback